253 related articles for article (PubMed ID: 17681768)
1. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
Darvesh S; McDonald RS; Darvesh KV; Mataija D; Conrad S; Gomez G; Walsh R; Martin E
Bioorg Med Chem; 2007 Oct; 15(19):6367-78. PubMed ID: 17681768
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.
Darvesh S; Macdonald IR; Martin E
Bioorg Med Chem Lett; 2013 Jul; 23(13):3822-5. PubMed ID: 23707254
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.
Darvesh S; McDonald RS; Penwell A; Conrad S; Darvesh KV; Mataija D; Gomez G; Caines A; Walsh R; Martin E
Bioorg Med Chem; 2005 Jan; 13(1):211-22. PubMed ID: 15582466
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
7. N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
González-Muñoz GC; Arce MP; López B; Pérez C; Romero A; del Barrio L; Martín-de-Saavedra MD; Egea J; León R; Villarroya M; López MG; García AG; Conde S; Rodríguez-Franco MI
Eur J Med Chem; 2011 Jun; 46(6):2224-35. PubMed ID: 21420206
[TBL] [Abstract][Full Text] [Related]
8. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
10. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
[TBL] [Abstract][Full Text] [Related]
11. Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity.
Weinstock M; Groner E
Chem Biol Interact; 2008 Sep; 175(1-3):216-21. PubMed ID: 18457821
[TBL] [Abstract][Full Text] [Related]
12. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
Alptüzün V; Prinz M; Hörr V; Scheiber J; Radacki K; Fallarero A; Vuorela P; Engels B; Braunschweig H; Erciyas E; Holzgrabe U
Bioorg Med Chem; 2010 Mar; 18(5):2049-59. PubMed ID: 20149667
[TBL] [Abstract][Full Text] [Related]
13. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.
Dillon GP; Gaynor JM; Khan D; Carolan CG; Ryder SA; Marquez JF; Reidy S; Gilmer JF
Bioorg Med Chem; 2010 Feb; 18(3):1045-53. PubMed ID: 20093035
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase.
Marcelo F; Silva FV; Goulart M; Justino J; Sinaÿ P; Blériot Y; Rauter AP
Bioorg Med Chem; 2009 Jul; 17(14):5106-16. PubMed ID: 19520578
[TBL] [Abstract][Full Text] [Related]
16. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
17. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Tang H; Zhao HT; Zhong SM; Wang ZY; Chen ZF; Liang H
Bioorg Med Chem Lett; 2012 Mar; 22(6):2257-61. PubMed ID: 22341944
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
Darvesh S; Arora RC; Martin E; Magee D; Hopkins DA; Armour JA
Exp Neurol; 2004 Aug; 188(2):461-70. PubMed ID: 15246845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
